Kyphon Prices $350 Million of Convertible Senior Notes
February 01 2007 - 2:25AM
PR Newswire (US)
SUNNYVALE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Kyphon Inc.
(NASDAQ:KYPH) today announced the pricing of $175 million aggregate
principal amount of Convertible Senior Notes due 2012 and $175
million aggregate principal amount of Convertible Senior Notes due
2014 in a private offering to qualified institutional buyers
pursuant to Rule 144A under the Securities Act of 1933, as amended
(the "Securities Act"). Upon the occurrence of certain events, the
notes will be convertible into cash up to the principal amount, and
if applicable, shares of common stock in respect of any conversion
value above the principal amount, based on an initial conversion
rate of 17.1951 shares of common stock per $1,000 principal amount
of notes, which is equivalent to an initial conversion price of
approximately $58.16 per share. Kyphon granted to the initial
purchasers a 30-day option to purchase up to $25 million aggregate
principal amount of additional notes of each series to cover
overallotments. Interest on the notes due 2012 will be paid
semiannually at a rate of 1.00% per year and interest on the notes
due 2014 will be paid semiannually at a rate of 1.25% per year.
Holders of the notes may require Kyphon to repurchase the notes for
cash equal to 100% of the principal amount to be repurchased plus
accrued and unpaid interest upon the occurrence of certain types of
fundamental changes. In connection with the offering, Kyphon
entered into convertible note hedge transactions which are intended
to reduce the potential dilution to Kyphon's common stockholders
upon any conversion of the notes. Kyphon also entered into warrant
transactions concurrently with the offering. Kyphon has been
advised that, in connection with establishing a hedge of the
convertible note hedge and warrant transactions, the counterparties
to those transactions or their affiliates expect to enter into
various derivative transactions with respect to Kyphon's common
stock concurrently with or shortly after the pricing of the notes.
The counterparties or their affiliates may also enter into or
unwind various derivative transactions with respect to Kyphon's
common stock and purchase or sell Kyphon's common stock in
secondary market transactions following the pricing of the notes
(and are likely to do so during any observation period relating to
the conversion of a note). Kyphon intends to use a portion of the
net proceeds of the offering to pay the cost of the convertible
note hedge transactions. This cost will be partially offset by
proceeds that Kyphon expects to receive from the sale of the
warrants. If the initial purchasers exercise their option to
purchase additional notes, Kyphon expects to use a portion of the
net proceeds from the sale of additional notes to enter into
additional convertible note hedge transactions. Kyphon may also
enter into additional warrant transactions, which would result in
additional proceeds to the company. Kyphon intends to use the
remaining net proceeds of the offering to retire approximately $310
million of the $425 million senior syndicated bank term loan used
to complete the acquisition of St. Francis Medical Technologies.
This press release is neither an offer to sell or a solicitation of
an offer to buy the notes nor shall there be any sale of the notes
in any state or jurisdiction in which such an offer, solicitation
or sale would be unlawful prior to the registration or
qualification thereof under the securities laws of any such state
or jurisdiction. Any offers of the notes will be made only by means
of a private offering memorandum. The notes and Kyphon's common
stock issuable upon the conversion of the notes have not been
registered under the Securities Act or the securities laws of any
other jurisdiction and may not be offered or sold in the United
States absent registration or an applicable exemption from
registration requirements. This press release contains
forward-looking statements within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995. Forward-looking
statements are based on management's current preliminary
expectations and are subject to risks, uncertainties and
assumptions, including the risk that Kyphon may be unable to
complete the offering. Other information on potential risk factors
that could affect Kyphon, its business and its financial results
are detailed in the company's periodic filings with the Securities
and Exchange Commission (SEC), including, but not limited to, those
risks and uncertainties listed in the section entitled
"Management's Discussion and Analysis of Financial Condition and
Results of Operations -- Factors Affecting Future Operating
Results," which can be found in Kyphon's annual report on Form 10-K
for the year ended December 31, 2005 filed with the SEC on March 3,
2006 and in Kyphon's quarterly report on Form 10-Q for the quarter
ended September 30, 2006 filed with the SEC on November 9, 2006.
KYPHG DATASOURCE: Kyphon Inc. CONTACT: investors and media, Julie
D. Tracy, Vice President, Investor Relations and Corporate
Marketing of Kyphon Inc., +1-408-548-6687, or Web site:
http://www.kyphon.com/
Copyright
Kyphon (MM) (NASDAQ:KYPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kyphon (MM) (NASDAQ:KYPH)
Historical Stock Chart
From Jul 2023 to Jul 2024